Evidence map›Paper›PMID 22918438›Full record

ArticleCell death and differentiation2013

The critical role of catalase in prooxidant and antioxidant function of p53.

M Y Kang, H-B Kim, C Piao, K H Lee, J W Hyun, I-Y Chang, H J You

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 131 citations in OpenAlex.

  1. On the Edge of Benefit and Harm: Reactive Oxygen Species in Cancer.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. eLife · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. bioRxiv : the preprint server for biology · 2024
    Article
  16. Frontiers in pharmacology · 2024
    Article
  17. Anti-tumor activity of silymarin nanoliposomes in combination with iron:International journal of pharmaceutics: X · 2023
    Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M Y KangDNA Damage Response Network Center, Chosun University School of Medicine, Gwangju, South Korea.
H-B Kim
C Piao
K H Lee
J W Hyun
I-Y Chang
H J You
Chosun University · KRJeju National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor suppressor p53 is an important regulator of intracellular reactive oxygen species (ROS) levels, although downstream mediators of p53 remain to be elucidated. Here, we show that p53 and its downstream targets, p53-inducible ribonucleotide reductase (p53R2) and p53-inducible gene 3 (PIG3), physically and functionally interact with catalase for efficient regulation of intracellular ROS, depending on stress intensity. Under physiological conditions, the antioxidant functions of p53 are mediated by p53R2, which maintains increased catalase activity and thereby protects against endogenous ROS. After genotoxic stress, high levels of p53 and PIG3 cooperate to inhibit catalase activity, leading to a shift in the oxidant/antioxidant balance toward an oxidative status, which could augment apoptotic cell death. These results highlight the essential role of catalase in p53-mediated ROS regulation and suggest that the p53/p53R2-catalase and p53/PIG3-catalase pathways are critically involved in intracellular ROS regulation under physiological conditions and during the response to DNA damage, respectively.

Indexed as

AntioxidantsApoptosisCatalaseCell Cycle ProteinsCell Line, TumorDNA DamageGene Knockdown TechniquesHCT116 CellsHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsOxidation-ReductionProtein BindingProto-Oncogene ProteinsReactive Oxygen SpeciesRibonucleotide ReductasesAntioxidantsCatalaseCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsProto-Oncogene ProteinsReactive Oxygen SpeciesRibonucleotide ReductasesRRM2B protein, humanTP53I3 protein, humanTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID22918438
PMCPMC3524643
OpenAlexW2024292131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.